Terns Pharmaceuticals appoints Bryan Yoon as Coo and General Counsel
Terns Pharmaceuticals appointed Bryan Yoon as Chief Operating Officer and General Counsel.He will be a part of the executive team and will be responsible for corporate strategy, business development, and certain corporate operational functions, including human resources, legal, and compliance.
Prior to becoming Chief Operating Officer and General Counsel at Terns, Yoon served as the Chief Administrative Officer, General Counsel, and Secretary of LogicBio Therapeutics. Before that, he served as the General Counsel and Secretary of Nightstar Therapeutics, until its acquisition by Biogen in June 2019. Prior to joining Nightstar, he held roles of increasing responsibility at Intercept Pharmaceuticals, a publicly trade biotechnology company, where he most recently was Senior Vice President, Legal Affairs and Secretary.